GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
WEDNESDAY, April 24, 2024 -- Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to be associated with an increased risk for thyroid cancer, according to a study published online April 10 in The BMJ.
Björn Pasternak, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Investor Update - April 24, 2024 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche sales increase by 2% (CER) in first quarter with both divisions growing in high single digit ex COVID-19
Group sales grew by 2%1 at constant exchange rates (CER) (-6% in CHF), driven by the strong growth of newer medicines and diagnostics. Excluding COVID-19-related products, sales increased by 7%. Going forward, there will be no further material impact of COVID-19 sales declineDue to the appreciation of the Swiss franc against most currencies,saleswere 6% lower when reported in CHFPharmaceuticals Divisionbase business2 grew by 7%, driven by strong sales of medicines to treat severe diseases, such as Vabysmo (eye diseases), Phesgo (breast cancer), Ocrevus (multiple sclerosis), Polivy (blood cancer) and Hemlibra (haemophilia A...
Source: Roche Media News - April 24, 2024 Category: Pharmaceuticals Source Type: news
Exo launches cardiac, lung AI apps for Exo Iris
Exo’s cardiac and lung AI applications are now available on Exo Iris, its handheld ultrasound device.
The company released Exo Iris last year. The point-of-care-ultrasound (POCUS) device now features pulsed-wave Doppler capabilities to offer physicians more opportunities to assess blood velocity and thus support diagnosis and deeper findings in cardiac, abdominal, and vascular applications, according to the firm.
Exo has U.S. Food and Drug Administration (FDA) 510k clearances for cardiac, lung, bladder, hip, and thyroid applications, and plans to double the number of clearances by 2025, it said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 23, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Impact of dental imaging on pregnant women and recommendations for fetal radiation safety: A systematic review
Conclusion: Few dental radiology studies have been conducted to determine the safe radiation threshold for pregnant women. Additionally, the reviewed articles did not provide numbers of dental examinations, by type, corresponding to this dose. Dental imaging examinations of pregnant women should not be restricted if clinically indicated. Ultimately, practitioners must be able to justify the examination and should adhere to the " as low as diagnostically acceptable, being indication-oriented and patient-specific " (ALADAIP) principle of radioprotection. (Source: Dental Technology Blog)
Source: Dental Technology Blog - April 18, 2024 Category: Dentistry Source Type: news
The Sorry State of Postpartum Care in America
It used to be taboo for moms to talk about their postpartum struggles. Today, not so much. In fact, it’s quite the opposite: it seems like everyone lately is talking about the difficulty of the postpartum period. On Google, if you search for “celebrity postpartum stories,” almost every result yields an article about famous moms discussing things like postpartum depression, anxiety, psychosis, and even pelvic prolapse. In March 2023, Brittany Mahomes, wife of Kansas City Chiefs quarterback, Patrick Mahomes, shared a warning with her 1.9 million followers, writing, “Just a daily reminder. Once you hav...
Source: TIME: Health - April 17, 2024 Category: Consumer Health News Authors: Maytal Eyal and Bridget Freihart Tags: Uncategorized freelance Source Type: news
Can Thyroid Dysfunction Cause Hormonal Imbalance? Can Thyroid Dysfunction Cause Hormonal Imbalance?
When to suspect that thyroid dysfunction is responsible for a hormonal imbalance, and how to determine whether it is the cause.American Thyroid Association (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 16, 2024 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Commentary Source Type: news
Microwave Ablation Feasible for T1N0M0 Papillary Thyroid Carcinoma
FRIDAY, April 12, 2024 -- For patients with multifocal papillary thyroid carcinoma (PTC), the rates of progression-free survival (PFS) do not differ between microwave ablation (MWA) and surgical resection (SR), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 12, 2024 Category: Pharmaceuticals Source Type: news
GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk GLP-1 Receptor Agonists Don't Raise Thyroid Cancer Risk
A cohort study in three Scandinavian countries found no significant increase in thyroid cancer risk with glucagon-like peptide 1 receptor agonists.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists
(MedPage Today) -- A Scandinavian cohort study suggested a popular class of diabetes drug did not put patients at an elevated risk for thyroid cancer, a longtime lingering concern with this drug class.
Compared with DPP-4 inhibitors, patients... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - April 10, 2024 Category: Urology & Nephrology Source Type: news
Taylor Swift Is Embracing the 5 Stages of Grief. Should You?
Call it the Five Stages of Grief (Taylor’s Version). Last week, ahead of the release of her album The Tortured Poets Department, Taylor Swift shared five new playlists that sort her old songs into stages: denial, anger, bargaining, depression, and acceptance. “These songs represent making room for more good in your life,” she says in a brief audio message accompanying the final playlist, acceptance. “Making that choice. Because a lot of time when we lose things, we gain things too.”
[time-brightcove not-tgx=”true”]
In the two months since Swift announced her new album, which co...
Source: TIME: Health - April 10, 2024 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized Evergreen healthscienceclimate Source Type: news
Ozempic, Wegovy Won't Boost Thyroid Cancer Risk: Study
WEDNESDAY, April 10, 2024 -- Wegovy, Ozempic and other drugs known as GLP-1 analogues have become wildly popular for controlling diabetes and helping folks lose weight.
There were concerns that longer term use of the drugs might raise users ' odds... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2024 Category: General Medicine Source Type: news
UltraCon: Microflow imaging on par with CEUS for guiding tumor ablation
AUSTIN -- Microflow imaging performs just as well as contrast-enhanced ultrasound (CEUS) for guiding tumor ablation and may be an economical alternative, according to research presented April 8 at UltraCon.
In her talk, Ziyue Hu, MD, from Sichuan Cancer Hospital in China highlighted findings showing that along with yielding comparable performance in treating thyroid nodules, microflow imaging in this area is less costly and invasive than CEUS.
“We found that in the microwave ablation procedure for thyroid nodules that … microflow imaging offers the advantages of reducing surgical expenses, which lessens the economic ...
Source: AuntMinnie.com Headlines - April 9, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Unleashing CAR-T cell therapy to destroy solid tumors in thyroid cancer
Mayo Clinic researchers will jump four hurdles to apply chimeric antigen receptor-T cell therapy (CAR-T cell therapy) to solid tumors in thyroid cancer. This regenerative immunotherapy has shown promising results in blood cancers, and new research is focused on using this treatment on more types of malignancies. "CAR-T cell therapy is unlike other therapeutics," says Saad Kenderian, M.B., Ch.B., a hematologist and cancer researcher. "Other therapies may slow down cancer. CAR-T cell therapy has shown… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 9, 2024 Category: Databases & Libraries Source Type: news
Acute thyroid hormone exposure in children: a national retrospective study using health data routinely collected by the French poison control centers - Paradis C, Courtois A, Vaucel JA, Blanc-Brisset I, Record C, Grenet G, Gomes E, Nardon A, Louviaux N, Labadie M.
To the Editor: The published case reports of L-thyroxine poisoning in children are scarce and the published case series included small numbers of patients, making it difficult to draw clear conclusions about L-thyroxine's exposure epidemiology and severity... (Source: SafetyLit)
Source: SafetyLit - April 6, 2024 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
